Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Sony posts record profit but warns of tariff impact, as it undergoes strategic changes under new CEO.
Menendez brothers granted resentencing bid after over three decades in prison for murdering their parents, with potential parole eligibility on the horizon.
Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
Sony posts record profit but warns of tariff impact, as it undergoes strategic changes under new CEO.
Menendez brothers granted resentencing bid after over three decades in prison for murdering their parents, with potential parole eligibility on the horizon.